Prior to joining Spruson & Ferguson (Asia), Esther was a Research Fellow in the National University of Singapore (NUS). She first started her postdoctoral training in a neuroscience lab, where she focused on establishing animal models for mixed dementia of Alzheimer’s disease and vascular dementia and identifying therapeutic targets. She then joined the Drug Discovery and Optimisation Platform under the Department of Pharmacology, where she was involved in drug screening and pharmacokinetic studies.
Esther obtained her Bachelor of Science (Honours) degree in Life Sciences and PhD degree in Pharmacology from NUS. During her PhD studies, Esther identified novel roles of sphingosine 1-phosphate receptor 2 in neural and cancer cells which had implications for the prevention of chemotherapy-induced peripheral neuropathy. Her thesis was awarded Lilly Medal and Prize for the best research thesis in pharmacology. In addition, Esther also published multiple scientific papers in well-regarded journals and presented in both local and international academic conferences.